| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |